Özet:

One of the organs that metastases the noncellular lung cancer (KHDAK) is the brain. When patients with brain metastases are not treated, the average lifetime is limited to months. The aim of this study is to show the oncological results of the application of surgical therapy for brain metastasis in patients who have done brain metastasis stage 4. In our clinic, the data of 59 patients diagnosed with ADHD between 2004 and 2012 and performed surgery due to the United Nations were recorded prospective and retrospective. The patient’s surgical and oncological results were observed. The right survival period was calculated as the time between the date on which the brain metastasis was diagnosed and the date of death or the date of follow-up. 51 of the patients were men, 8 women, and the average age was 56.92 (37-81) years. 55 patients were surgically exhausted, 4 subtotal exhausted. Mortality after surgery has not been identified. As a result of the pathological examination, the surgical limit was microscopically positive in 55 patients, while the tumor limit was microscopically positive in 4 patients. After the operation, all patients were given palliative cornea radiotherapy and systemic chemotherapy. 11 patients (18.6%) were given chemoradiotherapy to the primary mass in the lungs. 8 patients received lung lobectomy and 7 patients received pneumonectomy. The average survival period of the media was 12,00 (1,0-159,0) months. The survival rates of patients in the 12th, 24th and 60th months were 47.5%, 28.8%, and 13.5%, respectively. In three cases, over 10 years of overall survival was achieved. In patients with ADHD with brain metastasis, cranic metastasis can contribute positively to the survival of patients.

Anahtar Kelimeler: